右半结肠癌「尾侧入路+动脉优先」联合SMA右中线超D3淋巴结清扫:更符合肿瘤学原则?
该回顾性研究比较了168例右半结肠癌腹腔镜D3根治术,其中84例采用「尾侧入路+动脉优先」联合肠系膜上动脉(SMA)右中线超D3淋巴结清扫(CC+SMA组),84例采用传统内侧入路联合肠系膜上静脉(SMV)周围清扫(MA+SMV组)。结果显示两组基线、手术时间、出血量及总并发症率无显著差异,但CC+SMA组淋巴结清扫总数更多(29.44±5.90 vs 26.21±6.64,p<0.05),引流管拔除时间更长(4.05±1.79 vs 3.38±1.99天,p=0.022)。结论认为该技术安全可行,可能在淋巴结清扫数量上有优势,长期预后待观察。
要点
- 「尾侧入路+动脉优先」联合SMA右中线超D3清扫在右半结肠癌中安全可行。
- 该技术可增加淋巴结清扫总数,阳性淋巴结数无显著差异。
- 引流管拔除时间较长,但总并发症率无显著增加。
核心结论
- 「尾侧入路+动脉优先」联合SMA右中线超D3淋巴结清扫治疗右半结肠癌安全可行,可能在淋巴结清扫数量上有优势,长期预后待观察。
研究设计与样本
- 回顾性分析2017年1月至2018年3月168例右半结肠癌腹腔镜D3根治术病例,CC+SMA组84例,MA+SMV组84例。
主要发现
- 两组基线数据无显著差异(均p>0.05)。
- 手术时间170.04±43.10 vs 172.33±41.84 min,出血量91.07±55.12 vs 77.38±40.21 ml,均无显著差异(p>0.05)。
- 淋巴结清扫总数29.44±5.90 vs 26.21±6.64(p<0.05),阳性淋巴结数2.57±1.93 vs 2.51±1.05(p>0.05)。
- 总术后并发症率无显著差异,引流管拔除时间4.05±1.79 vs 3.38±1.99天(p=0.022)。
临床怎么用
- 右半结肠癌腹腔镜D3根治术可考虑采用「尾侧入路+动脉优先」联合SMA右中线超D3清扫,以增加淋巴结清扫数量。
- 需注意该技术可能延长引流管拔除时间。
局限性
- 回顾性研究,样本量有限,长期预后未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the feasibility and application value of a "caudal-to-cranial" plus "artery first" technique with beyond D3 lymph node dissection on the right midline of the superior mesenteric artery (SMA) for the treatment of right colon cancer METHODS: Clinical data consisting of 168 right colon cancer cases under going laparoscopic D3 radical resection, including 84 cases of "caudal-to-cranial" plus "artery first" technique with beyond D3 lymph node dissection on the right midline of the SMA (CC + SMA group) and 84 cases of conventional medial approach plus dissection around the superior mesenteric vein (MA + SMV group), from January 2017 to March 2018 were retrospectively analyzed. For CC + SMA group, our surgical method was to isolate the mesocolon using a caudal-to-cranial pathway and ligate blood vessels along the midline of the SMA. RESULTS: The baseline data was not significantly different between the two groups (all p > 0.05). The mean operation time and intraoperative blood loss in the CC + SMA and the MA + SMV groups were 170.04 ± 43.10 versus 172.33 ± 41.84 min and 91.07 ± 55.12 versus 77.38 ± 40.21 ml, respectively, which has no significant difference (p > 0.05). The mean number of total and positive harvested lymph nodes in the two groups were 29.44 ± 5.90 versus 26.21 ± 6.64 (p < 0.05) and 2.57 ± 1.93 versus 2.51 ± 1.05, respectively (p > 0.05). Compared with the MA + SMV group, there was no significant difference in total postoperative complication rate in the CC + SMA group. The time to pull out drainage tube in the CC + SMA group was longer than MA + SMV group (4.05 ± 1.79 versus 3.38 ± 1.99 day; p = 0.022). CONCLUSION: It is safe and feasible for the "caudal-to-cranial" plus "artery first" technique with beyond D3 lymph node dissection on the right midline of the SMA in right colon cancer. It may have some advantages in the number of lymph nodes dissection, and the long-term prognosis remains to be expected.
引用
- Yi X, Li H, Lu X, et al. "Caudal-to-cranial" plus "artery first" technique with beyond D3 lymph node dissection on the right midline of the superior mesenteric artery for the treatment of right colon cancer: is it more in line with the principle of oncology? Surg Endosc. 2019. PMID: 31617092. doi:10.1007/s00464-019-07171-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。